A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma

Published:2023-11-20 Issue:20 Volume:149 Page:18081-18091
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zhang Mang,Chen Yu,Wu Weili,Jin Feng,Li Yuanyuan,Long Jinhua,Luo Xiuling,Gong Xiuyun,Chen Xiaoxiao,Liu Lina,Tang Hong,Wang Ziqi

Funder

Qian Jiao He KY

Qian Ke He Ji

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05497-1.pdf

Reference22 articles.

1. Blanchard P, Bourhis J, Lacas B, Posner MR, Vermorken JB, Cruz Hernandez JJ et al (2013) Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol 31:2854–2860

2. Blanchard P, Landais C, Petit C et al (2016) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group. Ann Oncol 27:1

3. Chen Y, Ismaila N, Chua M et al (2021) Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline[J].J Clin Oncol. https://doi.org/10.1200/JCO.20.03237

4. Cohen Ezra E.W., Karrison Theodore G, Kocherginsky Masha, Mueller Jeffrey, Egan Robyn, Huang Chao H, Brockstein Bruce E, Agulnik Mark B, Mittal Bharat B, Yunus Furhan, Samant Sandeep, Raez Luis E, Mehra Ranee, Kumar Priya, Ondrey Frank, Marchand Patrice, Braegas Bettina, Seiwert Tanguy Y, Villaflor Victoria M, Haraf Daniel J, Vokes Everett E (2014) Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol 32(25):2735–43

5. Deng QQ, Huang XE, Ye LH, Lu YY, Liang Y, Xiang J (2013) Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev 14:413–417